Should deceased donors be tested for vCJD?

Cell and Tissue Banking

Volumn 6, Issue 4, 2005, Pages 263-270

  Warwick, Ruth M ^a   Eglin, Roger ^b  

^a Tissue Services   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Analyte; Assays; Deceased tissue donor; PrPsc (Prion Protein Scrapie); Tonsil; TSE (Transmissible Spongiform Encephalophy); Variant Creutzfeldt Jacob Disease (vCJD)

Indexed keywords

PRION PROTEIN;

ARTICLE; BIOASSAY; BLOOD TRANSFUSION; CADAVER DONOR; CENTRAL NERVOUS SYSTEM; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; HUMAN; IMMUNOHISTOCHEMISTRY; MEDICAL ETHICS; NONHUMAN; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; SCREENING; TISSUE TRANSPLANTATION; UNITED KINGDOM;

CREUTZFELDT-JAKOB SYNDROME; ETHICS, MEDICAL; HUMANS; TISSUE DONORS;

EID: 29444441882     PISSN: 13899333     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10561-005-1355-5     Document Type: Article

References (30)

1. A v National Blood Authority 2001. TNLR No 200 (QB Div) (QL) (Burton J).
2. BSE Inquiry Report 2000. www.bseinquiry.gov.uk.
3. M.E. Bruce I. McConnell R.G. Will J.W. Ironside 2001 Detection of variant Creutzfeldt Jacob disease infectivity in extraneural tissues Lancet 358 208-209 10.1016/S0140-6736(01)05411-3 11476840 1:STN:280:DC%2BD3MvivV2iuw%3D%3D
4. Centres for Disease Control 1987a Rapidly progressive dementia in a patient who received a cadaveric dura mater graft MMWR 36 4 49-55
5. Centres for Disease Control 1987b Update: Creutzfeldt-Jakob disease in a patient receiving a cadaveric dura mater graft MMWR 36 21 324-325
6. Centres for Disease Control 1989 Update: Creutzfeldt-Jakob disease in a second patient who received a cadaveric dura mater graft MMWR 38 3 37-43
7. Centres for Disease Control 1993 Creutzfeldt-Jakob disease in patients who received a cadaveric dura mater graft MMWR 42 28 560-563 Spain 1985-1992
8. Clarke P. and Ghani A.C. 2005. Projections of the future course of the primary vCJD epidemic in the UK: Inclusion of subclinical infection and the possibility of wider genetic susceptibility. J. Roy. Soc. Interface doi:10.1098/rsif.2004.0017 (published on line).
9. Clinical Incidents Panel 2001. The management of possible exposure to CJD through medical procedures: A Consultation Paper.pp 14.2 www.dh.gov.uk/assetRoot/04/07/82/21/04078221.pdf.
10. Council of Europe 2002. Guide to Safety and Quality Assurance for Organs, Tissues and Cells.
11. Department of Health. Quarterly analysis of the incidence of vCJD website www.dh.gov.uk.
12. P. Duffy J. Wolf G. Collins A.G. Devoe B. Steeten D. Cowen 1974 Possible person to person transmission of Creutzfeldt-Jakob disease New Engl. J. Med. 290 692-693 4591849 1:STN:280:CSuC3czltFQ%3D (Letter)
13. 'Guidelines for tissue banking' in UK Blood Transfusion and Tissue Transplantation Guidelines.2002. Sixth Edition. The Stationary OfficeLondon.Available at http://www.transfusionguidelines.org.uk.
14. A.F. Hill R.J. Butterworth S. Joiner G. Jackson M.N. Rossor D.J. Thomas A. Frosh N. Tolley J.E. Bell M. Spencer A. King S. Al-Sharraj J.W. Ironside P.L. Lantos J. Collinge 1999 Investigation of variant Creutzfeldt-Jacob disease and other human prion diseases with tonsil biopsy samples Lancet 353 9148 183-189 10.1016/S0140-6736(98)12075-5 9923873 1:STN:280:DyaK1M7itVOnug%3D%3D
15. D.A. Hilton E. Fathers P. Edwards J.W. Ironside J. Zajick 1998 Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jacob disease Lancet 352 9129 703-704 10.1016/ S0140-6736(98)24035-9 9728989 1:STN:280:DyaK1czpslajtA%3D%3D
16. D.A. Hilton A.L. Ghani L. Conyers P. Edwards L. McCardle D. Ritchie M. Penney D. Hegazy J.W. Ironside 2004 Prevalence of lymphoreticular prion protein accumulation in UK tissue samples J. Pathol. 203 733-739 10.1002/ path.1580 15221931 1:CAS:528:DC%2BD2cXmtFSmt7o%3D
17. J.W. Ironside D.A. Hilton A. Ghani N.J. Johnston L. Conyers L.M. McCardle D. Best 2000 Retrospective study of prion-protein accumulation in tonsil and appendix tissues Lancet 355 1693-1694 10.1016/ S0140-6736(00)02243-1 10905247 1:STN:280:DC%2BD3czmtFWrsA%3D%3D
18. P.G. Lindgren H. Hagberg B. Eriksson B. Glimelius A. Magnusson C. Sundstrom 1985 Excision biopsy of the spleen by ultrasonic guidance Brit. J. Radiol. 58 693 853-857 3916062 1:STN:280:BiiD2M%2FlsFc%3D
19. C.A. Llewelyn P.E. Hewitt R.S. Knight K. Amar S. Clousens J. Mackenzie R.G. Will 2004 Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion Lancet 363 417-421 10.1016/ S0140-6736(04)15486-X 14962520 1:STN:280:DC%2BD2c%2FnsVWhuw%3D%3D
20. E.E. Manuelidis J.N. Angelo E.J. Gorgacz J.H. Kim L. Manuelidis 1977 Experimental Creutzfeldt-Jakob disease transmitted via the eye with infected cornea New Engl. J. Med. 296 23 1334-1336 323711 1:STN:280:CSiC2s7gsFc%3D
21. Microbiological Safety of Blood Tissues for Transplantation, Department of Health: Guidance on the microbiological safety of human tissues and organs used in transplantation (NHS ExecutiveAugust 2000).
22. S. Muraca P. Chait B.L. Connolly K.M. Baskin M.J. Temple 2001 US-guided Core Biopsy of the Spleen in Children Radiology 218 200-206 11152802 1:STN:280:DC%2BD3MzitFCnsw%3D%3D
23. A.H. Peden M.W. Head D.L. Ritchie J.E. Bell J.W. Ironside 2004 Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient Lancet 364 527-529 10.1016/S0140-6736(04)16811-6 15302196
24. S. Sundar T.K. Jha C.P. Thakur J. Engel H. Sindermann C. Fischer K. Junge A. Bryceson J. Berman 2002 Oral Miltefosine for Indian Visceral Leishmaniasis New Engl. J. Med. 347 22 1739-1746 10.1056/NEJMoa021556 12456849 1:CAS:528:DC%2BD38XpsV2js7c%3D
25. S.J. Tabrizi C.L. Elliott C. Weismann 2003 Ethical issues in human prion diseases Brit. Med. Bull. 66 305-316 14522867 1:STN:280:DC%2BD3svmtVakuw%3D%3D
26. R.A. Tange D. Troost M. Limburg 1990 Progressive fatal dementia (Creutzfeldt-Jakob disease) in a patient who received homograft tissue for tympanic membrane closure Eur. Arch. Otorhinolaryngol. 247 199-201 10.1007/BF00178983 2198064 1:STN:280:By%2BA38bis1w%3D
27. V. Thadani P.L. Penar J. Partington R. Kalb R. Janssen L.B. Schonberger C.S. Rabkin J.W. Prichard 1988 Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft J. Neurosurg. 69 766-769 3054015 1:STN:280:BiaD3snjvVU%3D
28. UK Blood Transfusion Tissue Transplantation Guidelines - vCJD Position Statement) http://www.transfusionguidelines.org.uk/docs/pdfs/ position_statement_01_2005_02.pdf.
29. J.D.F. Wadsworth S. Joiner A.F. Hill T.A. Campbell M. Desbruslais P.J. Luthert J. Collinge 2001 Tissue distribution of protease resistant prion protein in variant Creutzfeldt Jakob disease using a highly sensitive immunoblotting assay Lancet 358 171-180 10.1016/S0140-6736(01)05403-4 11476832 1:CAS:528:DC%2BD3MXltlymsr4%3D
30. Warwick R. and Kearney J. 2004. Should tonsil be used as an analyte from cadaveric tissue donors to test for variant CJD? abstract, European Association for Tissue Banking EATB Prague.